retail news in context, analysis with attitude

Bloomberg reports that 23andMe, which got a lot of attention when it unveiled an at-home DNA testing kit, has "raised $115 million in venture-capital financing as it prepares to introduce a new consumer product and expands its drug-discovery arm."

The story notes that 23andMe "named for the 23 pairs of chromosomes in human cells, currently provides reports on consumers' ancestry." It pulled back from offering tests that allow people to use DNA testing to determine genetic susceptibility to certain diseases when the US Food and Drug Administration (FDA) said that the marketing was getting ahead of the science, but 23andMe now says that it expects to have a revamped and approved version available for sale before the end of the year.

The company also is "building a research lab for the therapeutics team and a sequencing laboratory that will be used both for the consumer product and for research efforts," the story says.
KC's View:
I think this is a fascinating story, because the whole notion of DNA testing that will allow people to address genetically predisposed disease states is one that could have enormous impact for the food industry. Diet is one of the ways in which people can work to prevent disease, and if you have some idea of what you;re going to get before you get it, food can be a powerful weapon.

This is technology that the industry should embrace wholeheartedly. Hell, if I were programming an industry conference, I'd get someone from 23andMe on the agenda as soon as possible ... because this has real implications for how food is sold and consumed.